Rha, S. Y., Lee, J., Ryu, M., Yin, L., Leconte, P., Bhagia, P., Oh, D. (2025). Pembrolizumab plus chemotherapy versus placebo plus chemotherapy in patients with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma enrolled in the Republic of Korea: KEYNOTE-859.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.428